Wound care—Part II: Tissue-engineered skin substitutes and other advanced wound therapies
Journal of the American Academy of Dermatology · 2026-09 · 95 (3) · 605-620
DOI: 10.1016/j.jaad.2025.06.045 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Fiona Haxho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, University of Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Skin, Artificial, Tissue Engineering, Wound Healing, Wounds and Injuries. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Biological products, including tissue-engineered skin tissue and growth factors, have become important treatment options for wound repair and regeneration. Tissue-based products include components that replicate the properties of normal human skin, such as fibroblast and keratinocyte cell culture, to promote healing and remodeling. These products can generally be categorized as epidermal, dermal, or composite skin replacements, and more recently as cellular, acellular, and matrix-like products (CAMPs). Selection is based on wound type, location, dimension, presence of undermining, and condition of the periwound skin. Despite multiple studies on cost-effectiveness, drawbacks to tissue-based products and advanced wound therapies include high cost, limited access, short shelf-life, specific storage requirements, and restricted indications. This review provides a summary of the indications and limitations of the types of CAMPs and biomaterials available for the treatment of wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Department of Medicine, University of Calgary, Alberta, Canada.
- Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.
- Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
- M. Mark Melin Gonda Vascular Center, Wound Clinic, Mayo Clinic, Rochester, Minnesota.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota. Electronic address: alavi.afsaneh@mayo.edu.
Zitieren
APA
Haxho, F., Lytvyn, Y., Shelley, A. J., Ortega-Loayza, A. G., Melin, M., & Alavi, A. (2026). Wound care—Part II: Tissue-engineered skin substitutes and other advanced wound therapies. Journal of the American Academy of Dermatology, 95(3), 605-620. https://doi.org/10.1016/j.jaad.2025.06.045
Vancouver
Haxho F, Lytvyn Y, Shelley AJ, Ortega-Loayza AG, Melin M, Alavi A. Wound care—Part II: Tissue-engineered skin substitutes and other advanced wound therapies. Journal of the American Academy of Dermatology. 2026;95(3):605-620. doi:10.1016/j.jaad.2025.06.045
BibTeX
@article{Haxho2026,
author = {Haxho, Fiona and Lytvyn, Yuliya and Shelley, Amanda J and Ortega-Loayza, Alex G and Melin, Mark and Alavi, Afsaneh},
title = {Wound care—Part II: Tissue-engineered skin substitutes and other advanced wound therapies},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {3},
pages = {605--620},
doi = {10.1016/j.jaad.2025.06.045}
}
EUVIMED